On Monday, SciSparc Ltd SPRC stock is trading higher with a session volume of 30.86 million compared to an average volume of 7.73 million as per data from Benzinga Pro.
U.S. stocks traded slightly lower toward the end of trading, with the S&P 500 edging lower on Thursday.
Friday, SciSparc Ltd. SPRC signed an exclusive patent license agreement with Polyrizon Ltd to out-license its SCI-160 program to treat pain.
SciSparc (NASDAQ: SPRC ) stock is on the rise Thursday after the clinical-stage pharmaceutical company provided investors with an update concerning its AutoMax Motors merger. The big news here is The Jerusalem District Court in Israel approving AutoMax's petition to convene special class meetings of shareholders to approve the SciSparc merger.
SciSparc (NASDAQ: SPRC ) stock is up on Tuesday after the clinical-stage pharmaceutical company announced a new patent application covering its weight loss treatment. SciSparc notes that this patent covers the company's collaboration with Clearmind Medicine (NASDAQ: CMND ).